Clinical Trial Search Results

In this study, participants with multiple types of advanced solid tumors that have progressed on standard of care therapy will be treated with pembrolizumab.

This study will evaluate the efficacy and safety of atezolizumab compared with placebo as adjuvant therapy after definitive local therapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck (SCCHN)

The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab in patients with advanced cancers.